Arkolith/Insider Trading/NRIX/Form 4

Ring Christine

Chief Legal OfficerNurix Therapeutics, Inc. (NRIX) · full profile →Form 4 · filed Nov 24, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$642K
Net Open-Market Flow
-$642K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 24, 2025Sell(S)38K$17.07$642K51K
Nov 24, 2025Option exercise(M)38K$1.86$70K88K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 24, 2025Option exercise(M)38K—$016K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001817199-25-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML